{"canonical":"https://abierto.us/vendors/nomocan-pharmaceuticals-llc-h9t8m7zbyar8","key":"H9T8M7ZBYAR8","name":"NOMOCAN PHARMACEUTICALS LLC","uei":"H9T8M7ZBYAR8","city":"NEW YORK","state":"NY","awards":1,"obligated":"0","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541715","cage":"7ER28","parent_name":"NOMOCAN PHARMACEUTICALS LLC","also_known_as":[],"country":"USA","actions":1,"first_action":"2026-09-01","last_action":"2026-09-01","breakdowns":{"naics":[{"key":"541715","name":null,"awards":1,"obligated":"0.00"}],"places":[{"key":"NY","name":null,"awards":1,"obligated":"0.00"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":1,"obligated":"0.00"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":1,"obligated":"0.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"0.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":1,"obligated":"0.00"}],"product_service_codes":[{"key":"AN12","name":null,"awards":1,"obligated":"0.00"}]},"awards_list":[{"award_key":"CONT_AWD_75N91025C00050_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91025C00050_7529_-NONE-_-NONE-/","piid":"75N91025C00050","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"H9T8M7ZBYAR8","recipient_name":"NOMOCAN PHARMACEUTICALS LLC","recipient_uei":"H9T8M7ZBYAR8","recipient_cage":"7ER28","recipient_city":"NEW YORK","recipient_state":"NY","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2026-09-01","last_action_date":"2026-09-01","actions":1,"obligated":"0","current_total_value":"499166.00","potential_total_value":"499166.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":16,"description":"EO 14398; NOMOCAN PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACT PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":1,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}